Skip to content

Development and Efficacy Evaluation of Integrated Chronic Care and Health Promotion Model for Patients With Coronary Artery Disease in Taiwan

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01357096
Enrollment
400
Registered
2011-05-20
Start date
2011-01-31
Completion date
Unknown
Last updated
2011-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction, Stable Angina

Keywords

intervention, CABG or PTCA

Brief summary

The hypothesis of this project is to examine whether the integrated health care program as the intervention group can reduce the recurrence and mortality of coronary artery-related diseases than the traditional one as the comparison group.

Interventions

BEHAVIORALIntegrated health care team

CAD education fryers, drugs counseling, diet intervention, individualized exercise program, body weight control, smoking cessation program, and distant CAD care monitoring

CAD education fryers

Sponsors

Kaohsiung Medical University Chung-Ho Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
No minimum to 85 Years
Healthy volunteers
No

Inclusion criteria

* patients who suffered from acute myocardial infarction or stable angina with intervention (CABG or PTCA)

Exclusion criteria

1. Age \> 85 yrs old. 2. Worse short-term prognosis (e.g.cancer, congestive heart failure NYHA IV) 3. Any systemic disease which will limit the exercise program (e.g. bed-ridden stroke) 4. Unable to participate in the trial due to any logic reasons

Design outcomes

Primary

MeasureTime frame
Death, non-fatal MI, non-fatal stroke, recurrent angina, emergency room (ER) visit due to any CV-related diseases or readmission due to any CV-related diseases confirmed by the physicians.one year

Secondary

MeasureTime frameDescription
BP, lipid, glucose, EBM drugs and self-care efficacyone year1. Blood pressure \< 140/90 mmHg (\< 130/80 mmHg in the diabetics and patients with chronic kidney disease) 2. Hypercholesterolemia:LDL \< 100 mg/dl 3. Diabetic:HbA1c \< 7% 4. Smoking cessation rate 5. Adherence rate of EBM medication including anti-platelet agent, beta-blocker, RAS blocker and lipid-lowering agent. 6. Efficacy of self care

Countries

Taiwan

Contacts

Primary ContactSheng-Hsiung Sheu, MD
Sheush@kmu.edu.tw88673121101
Backup ContactTsung-Hsien Lin, MD. PHD
lth@kmu.edu.tw88673121101

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026